Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Niki Rana"'
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 27:4019-4023
In the search for more potent peptide-based anti-cancer conjugates the generation of new, functionally diverse nucleolipid derived D-(KLAKLAK)2-AK sequences has enabled a structure and anti-cancer activity relationship study. A reductive amination ap
Publikováno v:
Bioorganicmedicinal chemistry letters. 26(15)
The synthesis, characterization and anti-cancer activity of a novel peptide nucleolipid bioconjugate is reported in this study. The prerequisite 5′-carboxy derived nucleolipid was synthesized following a five-step solution-phase approach and then c
Publikováno v:
ChemInform. 47
Nucleoside- and nucleotide-based chemotherapeutics have been used to treat cancer for more than 50 years. However, their inherent cytotoxicities and the emergent resistance of tumors against treatment has inspired a new wave of compounds in which the
Publikováno v:
ChemMedChem. 11(3)
Nucleoside- and nucleotide-based chemotherapeutics have been used to treat cancer for more than 50 years. However, their inherent cytotoxicities and the emergent resistance of tumors against treatment has inspired a new wave of compounds in which the
Autor:
David Sabatino, Niki Rana
Publikováno v:
Peptides 2015, Proceedings of the 24th American Peptide Symposium.
The apoptosis inducing (pro-apoptotic) peptide sequence, D-(KLAKLAK)2, has been classified as a potent antimicrobial agent [1]. Moreover, it was found to trigger cell death in bacteria without inducing cytotoxicity in mammalian cell types. The chemic